CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 9 enrolled
Drug / intervention
TempSure Firmdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04878172
NCT04878172N/ACompleted

Histological Study to Assess Safety and Efficacy of the TempSure Firm for Non-Invasive Lipolysis

Cynosure, Inc.·interventional·Posted May 7, 2021·Updated Apr 21, 2022

In Brief

A clinical study evaluating TempSure Firm for Non-invasive Lipolysis. Completed, enrolled 9 participants across 2 sites.

Detailed Summary

This is a prospective, open-labeled, non-randomized, multi-center clinical study to collect safety and efficacy data on the TempSure Firm. The intended use of the TempSure device is to use the Firm handpieces for non-invasive lipolysis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMay 7, 2021
Enrollment StartMar 12, 2021
Primary CompletionSep 28, 2021
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 5.2 years ago

Interventions

TempSure Firmdevice

The TempSure firm will be used on the abdomen for non-invasive lipolysis.